Sector Processa Pharmaceuticals, Inc. OTC Markets
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.100 USD | -38.38% |
|
-.--% | - |
| 07-29 | Processa Pharmaceuticals, Inc. acquired Vidya Therapeutics, Inc. for approximately $320 million. | CI |
| 07-29 | Processa Pharmaceuticals, Inc. - M&A Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.81% | -0.33% | -0.55% | +12.86% | +38.44% | +27.15% | +81.12% | -19.55% | - | 55.23B | |
| -3.74% | -6.32% | -7.99% | +11.77% | +4.16% | +42.70% | +64.45% | +190.17% | +5,755.69% | 53.75B | |
| -0.11% | +0.86% | -0.21% | -10.25% | -2.47% | -15.63% | -13.56% | -71.72% | - | 23.48B | |
| -1.58% | -5.51% | -4.81% | -25.56% | -41.69% | -3.51% | +375.36% | +312.56% | +786.38% | 22B | |
| +2.33% | -1.07% | +7.86% | +11.92% | +23.03% | +20.12% | -12.29% | -68.06% | - | 19.78B | |
| -1.23% | -3.15% | +2.73% | +9.11% | -9.03% | +26.00% | -31.88% | -34.96% | +52.90% | 17.44B | |
| +1.37% | -5.14% | +4.28% | +5.77% | +24.32% | +17.21% | +545.40% | - | - | 14.66B | |
| +1.16% | +0.58% | +2.87% | +25.89% | +27.70% | +51.87% | +181.96% | +232.17% | +509.69% | 14.07B | |
| -5.09% | -10.87% | -15.15% | +72.01% | +141.92% | +153.11% | +272.20% | +1,301.97% | +585.75% | 13.02B | |
| -9.83% | -9.25% | -8.16% | -4.69% | -15.32% | +70.11% | +139.94% | +464.72% | +6,474.80% | 11.37B | |
| +1.28% | +0.62% | +7.13% | +18.84% | +31.53% | +456.00% | +148.56% | +26.02% | +1,365.10% | 12.3B | |
| +2.41% | -4.07% | +0.69% | -25.31% | -15.53% | -38.26% | +132.52% | +89.76% | - | 10.95B | |
| +2.60% | -1.83% | -5.60% | +25.72% | +26.57% | +122.28% | +141.86% | +170.96% | +623.20% | 10.92B | |
| +5.00% | -10.28% | -7.76% | -37.37% | -23.16% | -49.59% | +533.96% | +83.36% | +92.00% | 10.72B | |
| -0.30% | -0.02% | +123.49% | +115.65% | +79.66% | +186.11% | +345.08% | +365.13% | - | 8.82B | |
| +3.71% | +1.51% | +14.33% | +36.33% | +209.83% | +487.04% | +604.86% | -33.77% | -15.42% | 8.93B | |
| +4.03% | -0.72% | +3.19% | -15.84% | +14.72% | +36.98% | +87.09% | -17.23% | - | 7.93B | |
| -2.32% | -11.93% | +7.99% | +23.50% | +10.96% | +14.78% | +312.86% | +320.07% | - | 7.69B | |
| +5.62% | +0.58% | -3.73% | -2.24% | +21.28% | +60.71% | +19.83% | +158.12% | - | 8.08B | |
| Average | +0.24% | -2.62% | +6.35% | +13.06% | +28.78% | +87.64% | +206.81% | +192.76% | +1,623.01% | 17.43B | |
| Weighted average by Cap. | -0.56% | -1.39% | +2.02% | +10.52% | +22.04% | +62.98% | +160.13% | +153.13% | +2,523.96% |
- Stock Market
- Stocks
- PCSA Stock
- PCSA Stock
- Sector Processa Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
